|
Molnupiravir has serious safety concerns: ICMR chief http://timesofindia.indiatimes.com/articleshow/88721354.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst "It can cause teratogenicity, mutagenicity, and it can also cause cartilage damage and can also be damage and can also be damaging to muscles." "More importantly, if this drug is given to a man or a woman, contraception has to be used for three months, as the child conceived during that period may have problems with teratogenic influences." “它会导致致畸性、致突变性，也会导致软骨损伤，也会对肌肉造成损伤。”“更重要的是，如果给男性或女性服用这种药物，必须避孕三个月，因为在此期间怀孕的孩子可能有致畸影响的问题。“ |
